PIK3CA was shown to be frequently increased in copy number in ovarian cancers, and the increased copy number is associated with increased PIK3CA transcription, p110α protein expression and PI3K activity and the treatment with the PI3K inhibitor LY294002 decreased proliferation and increases apoptosis [380]. This evidence concerns the gene PIK3CA and ovarian carcinoma.